Please provide your email address to receive an email when new articles are posted on . In a prospective, multicenter, adjudicator blinded clinical trial, Carl A. Deirmengian, MD, FAAOS, and ...
MADISON, Wis., Oct. 22, 2023 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced late-breaking data from the pivotal ...
Conclusions The K-D has fair test-retest reliability. The combination of sensitivity and specificity with any increase in time is better than other currently used objective measures of concussion.
Cisplatin (C) and gemcitabine (G) chemotherapy with concurrent irradiation (XRT), for the conservative treatment of invasive transitional bladder cancer (ITBC) patients: Clinical outcome and long-term ...
A blood-based test using cell-free DNA had high sensitivity for colorectal cancer, high specificity for advanced neoplasia, and some sensitivity for advanced precancerous lesions. A blood-based ...
VANCOUVER, British Columbia -- The novel multitarget stool RNA test (ColoSense) showed high sensitivity for detecting colorectal neoplasia among adults ages 45 and older, according to the phase III ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results